 | ||
   | ||
Email
Glossary |
|
Viability of Protease Inhibitors Jul 19, 1999 How are Protease Inhibitors useful in treating HIV? It seems that they would need to be in the blood before infection, or immediately upon infection to be able to work, otherwise the genetic information would already be inside the cell. What is the research being done in this direction? I but can't find much -it there a scientifically minded site I could go to? |
||||||||
 |
||||||||||
|
||||||||||
 |
| Response from Dr. Holodniy
 Studies are ongoing to look at post exposure prophylaxis (PEP) with protease inhibitors after high risk exposures. San Francisco General Hospital AIDS Program is taking the lead on this. Look back studies with AZT alone given within 4 hours of a significant healthcare worker exposure had significant benefit in preventing HIV infection. MH | ||||||||
 Get Email Notifications When This Forum Updates or Subscribe With RSS
|
||||||||||
|
||||||||||
Q&A TERMS OF USE
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.
Review our complete terms of use and copyright notice.
